Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Aarsland, D., Brønnick, K., Ehrt, U., De deyn, P. P., Tekin, S., Emre, M., & Cummings, J. L. (2007). Neuropsychiatric Symptoms in Patients with Parkinson’s Disease and Dementia: Frequency, Profile and Associated Care Giver Stress. Journal of Neurology, Neurosurgery and Psychiatry, 78(1), 36–42. https://doi.org/10.1136/jnnp.2005.083113
2. Ali, N., & Nater, U. M. (2020). Salivary Alpha-Amylase as a Biomarker of Stress in Behavioral Medicine. International Journal of Behavioral Medicine, 27(3), 337–342. https://doi.org/10.1007/s12529-019-09843-x
3. Ali, N., & Pruenssner, J. C. (2012). The Salivary Alpha Amylase over Cortisol Ratio as a Marker to Assess Dysregulations of the Stress Systems. Physiology & Behavior, 106(1), 65–72. https://doi.org/10.1016/j.physbeh.2011.10.003
4. Almela, M., Hidalgo, V., Villada, C., der Meij, L. V., Espín, L., Gómez-amor, J., & Salvador, A. (2011). Salivary Alpha-Amylase Response to Acute Psychosocial Stress: The Impact of Age. Biological Psychology, 87(3), 421–429. https://doi.org/10.1016/j.biopsycho.2011.05.008
5. Aoyagi, K., Karibe, H., Kawakami, T., Warita, S., Shimazu, K., & Ogata, K. (2011). Inter- and Intraobserver Reliability of the Hand-Held Monitor for Measuring Salivary Alpha-Amylase Level. Clinical Laboratory, 57(3–4), 253–257.